News
Atezolizumab plus chemotherapy superior to best supportive care in early lung cancer
- Author:
- Walter Alexander
Interim DFS analysis shows that relapse was higher among patients receiving best supportive care, compared with patients who received atezolizumab...
News
Combination treatment shows promise for men with advanced prostate cancer
- Author:
- Walter Alexander
The combination of nivolumab and rucaparib in a clinical trial showed clinical activity for metastatic prostate cancer cases with BRCA mutations....
News
Datopotamab deruxtecan for advanced NSCLC encouraging so far
- Author:
- Walter Alexander
The ongoing TROPION-PanTumor01 clinical trial shows an overall response rate of 35% for patients with advanced or metastatic NSCLC.
News
TULIP trial shows extended survival in HER2+ metastatic breast cancer
- Author:
- Walter Alexander
Progression-free survival was up to 7 months in some cases, but with adverse events.
News
ctDNA may be a better surrogate for survival than RECIST
- Author:
- Walter Alexander
ctDNA was detected in most patients with metastatic uveal melanoma. Treatment with tebentafusp was associated with a reduced tumor burden in 70%...
News
Intracranial atherosclerosis finding on MRA linked to stroke
- Author:
- Walter Alexander
An incidental diagnosis of intracranial atherosclerotic stenosis in stroke-free individuals should trigger a thorough assessment of vascular...
News
Esophageal cancer: Preoperative chemoradiotherapy benefit in CROSS persists over 10 years
- Author:
- Walter Alexander
The combination of paclitaxel and carboplatin with concurrent 41.4 Gy radiotherapy before surgery seems safe in...
News
Superior survival with sintilimab in squamous NSCLC
- Author:
- Walter Alexander
Sintilimab improved overall and progression-free survival, when compared with docetaxel.
News
Tislelizumab bests docetaxel in NSCLC
- Author:
- Walter Alexander
Tislelizumab was associated with better outcomes in patients with locally advanced or metastatic non–small cell lung cancer.
News
Antibiotics may prolong PFS in HCC patients on immunotherapy
- Author:
- Walter Alexander
Prior studies suggested that antibiotics reduce the efficacy of immunotherapy.
News
Tebentafusp improves OS: A first in metastatic uveal melanoma
- Author:
- Walter Alexander
Tebentafusp prolonged overall survival by nearly 6 months.
News
Personalized cancer vaccine shows early promise across tumor types
- Author:
- Walter Alexander
The vaccine consists of patient-specific synthetic neoantigen peptides and is given to patients in the adjuvant setting.
News
Healthy lifestyle may offset genetic risk in prostate cancer
- Author:
- Walter Alexander
In men at the highest risk of dying from prostate cancer, a healthy lifestyle cut the risk of fatal disease in half.
News
Black nonsmokers still at high risk for secondhand smoke exposure
- Author:
- Walter Alexander
The prevalence of SHS exposure among nonsmokers declined from 87.5% to 25.3% between 1988 and 2012.
News
Is the WHO’s HPV vaccination target within reach?
- Author:
- Walter Alexander
The WHO’s goal is to have HPV vaccines delivered to 90% of all adolescent girls by 2030.